The Endocannabinoid System Is Present in Embryos Before Brain Development Begins
Researchers found that the endocannabinoid system, including CB1 receptors and the enzymes that make and break down endocannabinoids, is active in embryos before nerve cells even begin forming.
Quick Facts
What This Study Found
Using chick and mouse embryo models, researchers demonstrated that all major components of the endocannabinoid system are present during very early embryonic development, before neurogenesis (the formation of nerve cells) begins. This included CB1 receptors, the endocannabinoids anandamide and 2-AG, and the enzymes responsible for their production and breakdown.
The finding suggests the endocannabinoid system plays a role in fundamental embryonic development processes that precede brain formation, and that exposure to THC during this early window could disrupt these processes.
Key Numbers
CB1 receptors, anandamide (AEA), 2-AG, and five metabolic enzymes (NAPE-PLD, DAGL-alpha, DAGL-beta, MAGL, FAAH) were all detected in pre-neurogenesis embryos in both chick and mouse models.
How They Did This
The study used biochemical techniques including analysis of receptor levels, endocannabinoid concentrations, and enzyme presence in chick and mouse embryo models at developmental stages before and during neurogenesis.
Why This Research Matters
In utero THC exposure has been associated with increased risk of neurodevelopmental problems in offspring. This study provides a biological mechanism: if the endocannabinoid system is active even before brain development begins, cannabis exposure during the earliest stages of pregnancy could interfere with fundamental developmental processes.
The Bigger Picture
This research extends the window of potential vulnerability to cannabis exposure further back in development than previously understood. If the endocannabinoid system is critical for pre-neurogenesis development, the earliest weeks of pregnancy, often before a woman knows she is pregnant, could represent a particularly sensitive period.
What This Study Doesn't Tell Us
The study used animal models (chick and mouse), which may not perfectly mirror human embryonic development. Detecting the presence of endocannabinoid system components does not prove they are functionally critical at this stage. The study did not test the effects of THC exposure at these early timepoints.
Questions This Raises
- ?What specific developmental processes does the endocannabinoid system regulate before neurogenesis?
- ?Does THC exposure during this pre-neurogenesis window produce different outcomes than later exposure?
- ?Are these findings replicated in human embryonic tissue?
Trust & Context
- Key Stat:
- All major endocannabinoid system components were present before neurogenesis
- Evidence Grade:
- Animal study in chick and mouse embryos; demonstrates presence of the system but does not test functional consequences of disruption.
- Study Age:
- Published in 2012. Research on endocannabinoid signaling in early development has continued to expand.
- Original Title:
- Cannabinoid receptor 1 signaling in embryo neurodevelopment.
- Published In:
- Birth defects research. Part B, Developmental and reproductive toxicology, 95(2), 137-50 (2012)
- Authors:
- Psychoyos, Delphine, Vinod, K Yaragudri(3), Cao, Jin, Xie, Shan, Hyson, Richard L, Wlodarczyk, Bogdan, He, Weimin, Cooper, Thomas B, Hungund, Basalingappa L, Finnell, Richard H
- Database ID:
- RTHC-00607
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why does it matter that the endocannabinoid system exists before brain development?
If the endocannabinoid system is active before nerve cells even begin forming, it likely plays a role in fundamental embryonic processes. THC from cannabis use could interfere with these processes during the very earliest weeks of pregnancy, potentially before a woman is aware she is pregnant.
Does this prove cannabis causes birth defects?
No. This study showed the endocannabinoid system is present in early embryos, which is a necessary prerequisite for THC to have an effect, but it did not directly test whether THC exposure at this stage causes developmental problems. It identifies a potential vulnerability window that needs further investigation.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-00607APA
Psychoyos, Delphine; Vinod, K Yaragudri; Cao, Jin; Xie, Shan; Hyson, Richard L; Wlodarczyk, Bogdan; He, Weimin; Cooper, Thomas B; Hungund, Basalingappa L; Finnell, Richard H. (2012). Cannabinoid receptor 1 signaling in embryo neurodevelopment.. Birth defects research. Part B, Developmental and reproductive toxicology, 95(2), 137-50. https://doi.org/10.1002/bdrb.20348
MLA
Psychoyos, Delphine, et al. "Cannabinoid receptor 1 signaling in embryo neurodevelopment.." Birth defects research. Part B, 2012. https://doi.org/10.1002/bdrb.20348
RethinkTHC
RethinkTHC Research Database. "Cannabinoid receptor 1 signaling in embryo neurodevelopment." RTHC-00607. Retrieved from https://rethinkthc.com/research/psychoyos-2012-cannabinoid-receptor-1-signaling
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.